The Tryptophan System in Cocaine-Induced Depression

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Major depression disorder (MDD) frequently co-occurs with cocaine use disorder (CUD).
• Distinguishing between primary MDD and cocaine-induced MDD is crucial for effective treatment but remains challenging.
• The underlying biological mechanisms of comorbid MDD in CUD are not fully understood.

Purpose of the Study:

• To investigate the involvement of the tryptophan/serotonin (Trp/5-HT) system and the kynurenine pathway in different forms of MDD comorbid with CUD.
• To compare these neurochemical pathways in individuals with CUD-primary-MDD, CUD-induced-MDD, MDD, and healthy controls.

Main Methods:

• Employed an acute tryptophan depletion (ATD) test in a randomized, double-blind, crossover, placebo-controlled design.
• Measured plasma concentrations of tryptophan (Trp) and serotonin (5-HT) following ATD.
• Assessed markers of enzymatic activity within the kynurenine pathway, including indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, kynurenine aminotransferase (KAT), and kynureninase.

Main Results:

• Tryptophan (Trp) levels decreased across all groups after ATD.
• Significant differences were observed between CUD-induced-MDD and MDD in 5-HT plasma concentrations and the Kyn/5-HT ratio.
• No significant differences were found between CUD-primary-MDD and MDD in these markers.

Conclusions:

• Cocaine-induced MDD appears to have a distinct pathogenesis compared to primary MDD, with less involvement of the tryptophan system.
• Findings suggest that CUD-induced MDD may be more closely related to other neurotransmitter pathways.
• These results indicate a potential need for tailored pharmacological treatment approaches for CUD-induced MDD.